TABLE 4

Thirty-Two Patients Who Underwent at Least 1 Salvage (Curative-Intent) ¹³¹I Treatment

Patient no.	Age (y)	Met.*	Therapy date	GBq	Dose to BM	Dose to tumor or second organ at risk^†	Tg^‡			Surv.^§	Cause of death^¶
Patient no.	Age (y)	Met.*	Therapy date	GBq	Dose to BM	Dose to tumor or second organ at risk^†				Surv.^§	Cause of death^¶	Before therapy	After therapy
1	65	1, 3	03/94	24.8	3 Gy	>100 Gy	13,100	860
		1, 3	06/95	24.2	3 Gy	Palliative	5,390	2,520	2.3	DTC
2	79	1, 2	05/94	33.5	3 Gy	>100 Gy	91	9	7.2
3	58	2, 4	01/97	12.4		2 kGy, lymph node	60.6	18	5.0
4	76	1	12/91	3.2		30 Gy, lungs	7,100	?
		1	03/92	8.5		30 Gy, lungs	4,950	122	1.1	Other
5	70	2	07/96	7.4	3 Gy	>100 Gy	156	0.7	5.4
6	30	1	05/98	28.0	3 Gy	Micro Met., lung	14.7	1.0	3.4
7	45	1	02/93	21.5	3 Gy	Multiple Met., lung	21,000	8,260
		1	09/93	26.1	3 Gy	Multiple Met., lung	38,000	7,340	7.2	DTC
8	60	2	06/91	13.3	2.5 Gy	>100 Gy	845	?
		1	11/93	18.0	3 Gy	100 Gy	6,520	3,620	9.5
9	76	1	09/97	23.4	1.7 Gy	660 Gy	680	430
		1	10/98	15.7	1.5 Gy	300 Gy	1,780	43,600	3.4	Other
10	58	2	03/89	25.1	1.5 Gy	300 Gy	>999	<1
		2	10/92	17.5	3 Gy	50–250 Gy	940	680
		2	03/94	25.2	2.5 Gy	400 Gy	1,400	350
		2	06/99	13.0	1 Gy	Palliative	5,600	?	10.9	DTC
11	31	1	02/96	10.1	3 Gy	Micro Met., lung	240	0.4	5.4
12	62	1	11/97	22.0	1 Gy	400 Gy	17	?	2.5
13	68	2	12/96	13.3	3 Gy	900 Gy	2,400	64
		2	07/97	31.8	2 Gy	120 Gy	1,250	3.3	4.6
14	72	3	05/97	25.4	3 Gy	>200 Gy	14,400	?	3.2	DTC
15	69	3	02/95	22.9	3 Gy	>100 Gy	3,200	165	3.4	Other
16	62	4	04/94	21.0	3 Gy	>100 Gy	10,500	11	7.8
17	64	1	02/96	28.3	3 Gy	21 Gy, lungs	172	<0.3	5.8
18	69	1, 2	09/93	8.0		30 Gy, lungs	>999	42,400	3.2	DTC
19	55	1, 2	04/96	38.5	3 Gy	>200 Gy	221	132
		1, 2	10/98	11.2	1 Gy	Palliative	2,900	512	5.8
20	65	2	01/94	26.2	3 Gy	No exact calculation	1,580	760	1.3	Other
21	66	2	01/97	17.0	3 Gy	>150 Gy	73,600	13,200
		2	10/97	35.2	2 Gy	>120 Gy	23,200	4,300	5.1
22	77	1, 5	07/97	13.7	3 Gy	>150 Gy	4.3	<0.3	4.3
23	64	1, 5	02/95	22.6	3 Gy	1 kGy, local recurrence	18,300	13,100
		1, 5	02/96	27.4	3 Gy	430 Gy, local recurrence	16,400	?	1.1	DTC?
24	72	2	04/93	22.6	3 Gy	>100 Gy	685	<0.3	8.8
25	25	4	05/98	4.2		380 Gy, lymph node	54	0.7	3.3
26	64	1, 2	08/98	30.1	3 Gy	217 Gy	126	0.7	3.3
27	27	1, 4	02/97	27.8	2 Gy	Micro Met., lung	4.8	<0.3	4.6
28	57	2	10/97	7.0		1,000 Gy	7.4	0.3	4.2
29	39	4	11/99	26.2	1.2 Gy	400 Gy, mediastinal nodes	11	<0.3	2.3
30	75	1, 2	07/01	9.1	2 Gy	130 Gy, bone Met.	4,630	560	0.6
31	74	1, 2	01/00	25.8	2.2 Gy	140 Gy	1,405	502	2.1
32	72	1	05/00	27.7	3 Gy	Multiple Met., lung	4,040	450	1.2

↵* Met. = metastasis or metastases (1 = lung, 2 = bone, 3 = other, 4 = lymph nodes, 5 = local recurrence).
↵^† Dose to tumor: calculated tumor dose; if mentioned, dose to second organ at risk or reason why no exact dose could be given. Met = metastasis or metastases.
↵^‡ Tg before and after (minimum) therapy: TSH < 0.1; TSH > 20 (italics).
↵^§ Surv. = survival (years after first curative-intent radioiodine therapy).
↵^¶ DTC or other (other than DTC).